ZACCARDELLI DAVID (President and CEO) sold 2.9% of their position (400K shares) of VERONA PHARMA PLC on the open market
Open‑market sale worth $3.73M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/29/2025ACC: 0001104659-25-054260
DirectorOfficer· President and CEO
Since Jan 2021
-400K
Net shares
Net seller
$3.73M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
400K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
−33.60K
Price / share
$9.53
Trade value
$320.18K
% of position
0.2%
5/27/2025
13.99M→13.96M
Ordinary Shares
Direct
Shares
−157.70K
Price / share
$9.30
Trade value
$1.47M
% of position
1.1%
5/28/2025
13.96M→13.80M
Ordinary Shares
Direct
Shares
−208.70K
Price / share
$9.33
Trade value
$1.95M
% of position
1.5%
5/29/2025
13.80M→13.59M
Total
Net shares
−400K
Net value
-$3.73M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/27/2025 | S · Sale | −33.60K | $9.53 | $320.18K | 0.2% | 13.99M | 13.96M |
| Ordinary Shares Direct | 5/28/2025 | S · Sale | −157.70K | $9.30 | $1.47M | 1.1% | 13.96M | 13.80M |
| Ordinary Shares Direct | 5/29/2025 | S · Sale | −208.70K | $9.33 | $1.95M | 1.5% | 13.80M | 13.59M |
| Total | −400K | -$3.73M | ||||||
Derivative Transactions0
No derivative transactions reported